Arne Skerra, Ph.D. (CEO)

Managing Director, Co-founder

 

Dr. Arne Skerra is Professor at the Technische Universität München and a leading expert in therapeutic protein engineering. Besides PASylation, he invented several other commercially successful technologies such as bacterially produced antibody fragments, the Strep-tag®, and Anticalins®.

Uli Binder, M.Sc. (CTO)

Chief Technology Officer, Co-founder

 

Uli Binder studied molecular biotechnology and business administration. He did his Ph.D. studies at the Technische Universität München and has extensive experience in protein engineering.